Application of isotope-selective nondispersive infrared spectrometry (IRIS) for evaluation of [[sup.13]C]octanoic acid gastric-emptying breath tests: comparison with isotope ratio-mass spectrometry (IRMS).
Diagnosis of impaired gastric emptying and control of therapy is generally based on the assessment of gastric emptying of solids because disturbances of solid emptying precede impairment of liquid emptying . For the measurement of gastric emptying, various methods have been described. [sup.99m]Tc-colloid-based scintigraphy is considered the reference method [7,12-14]; other procedures are real-time ultrasonography [9,11], radiopaque method , metal sphere method , and sulfamethiazole capsule method .
Previously, a noninvasive [[sup.13]C] octanoic acid gastric-emptying breath test was developed by Ghoos et al., based on the analysis of the time course of [sup.13]C-label enrichment in [sup.13]C[O.sub.2] in the exhaled air . For sensitive and accurate measurement of [sup.13]C[O.sub.2]/[sup.12]C[O.sub.2] ratio in breath samples, isotope ratio-mass spectrometry (IRMS) is commonly used as an established standard method . (5)
Some studies indicate that infrared diode laser spectroscopy , infrared heterodyne ratiometry X19], and particularly infrared spectroscopy [20-24] may prove to be alternative, far more simple, and easy-to-operate optical methods for [sup.13]C[O.sub.2] analysis in breath samples under routine laboratory conditions.
A newly designed X25] nondispersive infrared spectrometer for [sup.13]C[O.sub.2] measurements in breath samples (IRIS) has now become commercially available. In the present study we examined the applicability of the IRIS method as compared with standard IRMS for evaluation of the [[sup.13]C] octanoic acid breath test parameters.
Subjects and Methods
Informed consent was obtained from all subjects entering the study. The present data were obtained in gastric-emptying tests performed in clinical studies on diabetic gastroparesis. The clinical outcome of the studies and the medical implications will be reported elsewhere. The study protocol was in accordance with the Helsinki Declaration as revised in 1983 and had been approved by the Ethik-Kommission of the Heinrich-Heine-Universitat Dusseldorf.
Twenty healthy volunteers (11 male, 9 female, mean age 35.4 [+ or -] 11.9 years, weight 73.4 [+ or -] 13.2 kg, height 173 [+ or -] 11 cm) and 62 diabetic patients (31 male, 31 female, mean age 37.0 [+ or -] 15.9 years, weight 70.3 [+ or -] 13.3 kg, height 173 [+ or -] 9 cm) recruited from the inpatient clinic of the Diabetes Forschungsinstitut were investigated. Insulin-dependent patients received a subcutaneous injection of the usual insulin 30 min before the test meal. The insulin dose was adjusted according to the fasting blood glucose concentrations and the meal modification .
[[sup.13]C]OCTANOIC ACID BREATH TEST
Breath tests were performed as previously described by Ghoos et al. . In short, overnight fasted healthy subjects and diabetic patients ingested a test meal between 0800 and 0830 within 10 min. The meal comprised a scrambled egg with the yolk mixed with 0.1 mL of [[sup.13]C] octanoic acid (1-[sup.13]C, 99%; Promochem, Wesel, Germany) and yolk and egg white fried separately, two slices of white bread, and 5 g of margarine (42% carbohydrate, 18% protein, 40% fat; ~250 cal), followed by 150 mL of mineral water. During the following 4-h test period the subjects stayed in a sitting position in a separate test room. Breath samples for [sup.13][O.sub.2] measurement were collected in 1.5-L breath bags (Tecobag; Tesseraux Container, Burstadt, Germany) every 10 min during the first hour and thereafter in 15-min intervals. Control (baseline) samples were collected before the test meal. For [sup.13]C[O.sub.2] analysis by IRMS, aliquots were withdrawn from each bag and filled in duplicate into 10-mL evacuated tubes (Vacutainer Tube; Becton Dickinson, Heidelberg, Germany) by means of a 50-mL syringe (Perfusor-Spritze, B.Braun, Melsungen, Germany) equipped with a three-way stopcock.
ANALYSIS OF [sup.13]C[O.sub.2] IN BREATH
Measurement of [sup.13]C[O.sub.2] in exhaled air was carried out by standard mass spectrometric methods with a Finnigan MAT (Bremen, Germany) Model 251 isotope ratio-mass spectrometer as previously described .
IRIS was performed with the infrared spectrometer at our disposal (from Wagner Analysentechnik, Worpswede, Germany). The principle of this recently developed new device for [sup.13]C[O.sub.2] measurement in gaseous samples has been described [23; Scheme 1]. Breath samples were transferred directly from the breath bags into the measuring cuvettes by means of a pump. About 300 mL of gas are needed for thorough flushing of cuvettes and reliable measurement. All data for [sup.13]C enrichment in breath C[O.sub.2] were read out as baseline-corrected [DELTA][delta] values, as these are used for the diagnostic evaluation of breath tests .
CALCULATIONS AND STATISTICS
Evaluation of the breath tests was performed as outlined by Ghoos et al. . The increase in breath [sup.13]C[O.sub.2] after ingestion of [[sup.13]C] octanoic acid (determined as 08 values) was used to calculate the extra [sup.13]C[O.sub.2] exhalation rate assuming a mean endogenous C[O.sub.2] production of 5 mmol x [min x [m.sup.2] [(body surface)].sup.-1] . Body surface was estimated by using the weight-height formula given by Haycock et al. . Results are expressed as the percentage of [sup.13]C[O.sub.2] recovery per min and cumulatively over the test period of 4 h.
As suggested by Ghoos et al. , the data were used for mathematical curve fitting. Nonlinear regression analysis as provided by the SOLVER procedure of the Excel 5.0 program was used, applying the formulas y = [at.sup.b] x [e.sup.-ct] and y = m x [(1- [e.sup.-kt]).sup.[beta]], respectively (; see  for discussion). According to Ghoos et al. , the following three main breath test parameters of gastric emptying were computed from the coefficients k, [beta], and a, respectively: half emptying time [[t.sub.1/2,breath], = (1/k) x ln(1-[2.sup.-1/[beta]]) - 66], lag phase [[t.sub.lag,breath] = (1/k) x 1n([beta])-66], and gastric emptying coefficient [GEC = ln(a)].
In two diabetic patients, markedly delayed gastric emptying resulted in a poor curve fitting and insignificant values for the gastric emptying parameters. Therefore, the parameters of these patients were excluded from the parameter evaluation.
In general, results are presented as means [+ or -] SD with the number of determinations in parentheses. Linear regression analysis (least-square method) was used for statistical comparison of parameters.
Because of the limited volume of an individual breath, standard procedures for evaluation of between- and within-run reproducibility were not applicable with authentic breath samples. Therefore, two consecutive series of measurements were performed on samples from a representative number of breath tests. Statistical evaluation of repeatability was carried out by using linear regression analysis.
For evaluation of repeatability, samples from several [[sup.13]C] octanoic acid gastric-emptying breath tests were subjected to repeated analysis of [sup.13]C[O.sub.2] by IRMS (n = 20) or IRIS (n = 20). [sup.13]C enrichment in the samples was evenly distributed and ranged from 0 to ~20 [DELTA][delta] values (data not shown). When the results from the first and second analysis run were plotted on the x- and y-axes, respectively, linear regression analysis of the data yielded standard deviations of repeated IRMS [y = 0.034 (SD 0.013) + 0.999 (SD 0.001)x, r = 0.9997, n = 360] and IRIS [y = 0.076 (SD 0.074) + 0.984 (SD 0.009)x, r = 0.9857, n = 360] measurements ([S.sub.y|x]) of [+ or -] 0.1 [DELTA][delta] values and [+ or -] 0.6 [DELTA][delta] values, respectively.
In Table 1, the gastric emptying parameters are listed as computed from the IRIS and IRMS measurements, together with an analysis of parameter reproducibility. The calculated bias of the duplicate determinations with IRIS (IRMS results given in parentheses) of gastric half-emptying time, lag phase, and GEC in the 20 breath tests amounted to 2.4 [+ or -] 2.1 min (0.6 [+ or -] 0.6 min), 2.6 [+ or -] 3.0 min (0.2 [+ or -] 0.2 min), and 0.03 [+ or -] 0.04 (0.01 [+ or -] 0.01), respectively. These values were equivalent to a mean relative deviaton of 2.7 [+ or -] 2.3% (0.8 [+ or -] 0.7%), 6.1 [+ or -] 5.8% (1.1 [+ or -] 1.9%), and 1.0 [+ or -] 0.9% (0.3 [+ or -] 0.3%), respectively, when related to the individual gastric emptying parameters of the investigated subjects.
For further evaluation of the IRIS method, IRIS and IRMS measurements were performed in parallel with breath samples from a representative number of [13C] octanoic acid gastric emptying breath tests performed in diabetic patients (n = 60). When plotted, some scatter of the individual data points around the regression line was observed (Fig. 1). However, when the data were used to compute the gastric emptying parameters of the patients, a good agreement was obtained between the results of both methods (Table 2, Fig. 2). When related to the gastric emptying parameters as estimated by nonlinear regression analysis on the basis of IRMS measurements, the bias of IRIS-based determinations of gastric half-emptying time (range 24-252 min), lag phase (range -23-140 min), and GEC (range 1.7-3.9) in these breath tests amounted to 5.8 [+ or -] 4.1 min, 2.6 [+ or -] 2.4 min, and 0.11 [+ or -] 0.07 (n = 60), respectively. The variation (-SD) of the IRIS results relative to the IRMS results (=100%) were [+ or -] 7.2%, [+ or -] 9.9%, and [+ or -] 3.2%, respectively. The overall means (and standard deviations) of the gastric emptying parameters of the investigated diabetic patients were practically identical (Table 2).
The [[sup.13]C]octanoic acid gastric-emptying breath test is a noninvasive procedure for the assessment of gastric emptying rate of solids and has been validated in healthy subjects [16,29] and diabetic patients [71 by using standard scintigraphic methods. For [sup.13]C[O.sub.2] analysis in diagnostic breath tests, IRMS is generally applied as a well-established reference method. So far, the principle of infrared spectrometry has been only used in a few limited studies on the detection of Helicobacter pylori infections by [[sup.13]C]urea breath tests [22-24].
In the present study, we evaluated the routine clinical use of a commercially available infrared spectrometer (IRIS) for the [[sup.13]C] octanoic acid gastric-emptying breath test procedure.
[FIGURE 1 OMITTED]
As is evident from the data presented, repeatability of IRIS [sup.13]C[O.sub.2] measurements in breath test samples was somewhat less superior than the expected excellent repeatability of IRMS analyses. According to these data, IRIS data may be expected to deviate up to about [+ or -] 1.2 [DELTA][delta] values (i.e., [+ or -] 2SD, 95% confidence level) from the IRMS results. This degree of deviation was verified experimentally in the present study (Fig. 1). It is noteworthy, however, that neither the variability of repeated IRIS measurements nor the deviations from the IRMS data exceeded the natural fluctuations in the [sup.13]C[O.sub.2] content in expired air of overnight fasted subjects (SD about [+ or -] 0.7 [delta] value [261).
The statistical variability of the IRIS data was extenuated in the evaluation of [[sup.13]C] octanoic acid breath tests, where calculation of the gastric emptying parameters by nonlinear regression analysis was based on [sup.13]C[O.sub.2] analyses in multiple breath samples with a wide range of [sup.13]C-enrichment. Thus, the variability of gastric emptying parameters as obtained in repeated IRIS determinations (Table 1) and in the comparative IRIS vs IRMS measurements (Table 2) was far lower than the inter- ([7,16], Table 1) and intraindividual variability [7,16] that had been found in healthy subjects and patients; e.g., the reported gastric half-emptying time in overnight fasted healthy subjects is ~80 min and the intra- and interindividual standard deviation about [+ or -] 30 min ([7,16], Table 1), whereas the standard errors of estimate of the half-emptying time in the repeated IRIS analyses and in the comparison of the IRIS with the IRMS determinations was [+ or -] 3 min (Table 1) and [+ or -] 6 min (Table 2), respectively.
[FIGURE 2 OMITTED]
Although the accuracy of IRIS determinations of [sup.13]C enrichment in breath C[O.sub.2] samples is notably lower than that of standard IRMS, the present results suggest that the IRIS method is suitable for the evaluation of the [[sup.13]C] octanoic acid gastric-emptying breath test procedure under routine clinical conditions. In some cases of doubt, however, in which the gastric emptying parameters are just on the border between normal and pathological values, it may be advisable to reexamine the outcome by repetition of the breath test.
We are indebted to M. Karallus, A. Pour Mirza, and to B. Teuber for assistance in performing the [[sup.13]C]octanoic acid breath tests, to A. Pfundstein for technical assistance in IRMS measurements, to L. Bohne for some IRIS measurements, to K. Dannehl for statistical advice, and to M. Haisch for advice with Scheme 1. The support and valuable discussions of F.A. Gries and U. Wendel are gratefully acknowledged.
[1.] Chaudhuri TK, Fink S. Gastric emptying in human disease states. Am J Gastroenterol 1991;86:533-8.
[2.] Duan LP, Braden B, Caspary WF, Lembcke B. Influence of cisapride on gastric emptying of solids and liquids monitored by 13C breath tests. Dig Dis Sci 1995;40:2200-6.
[3.] Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli Labate AM, Monetti N, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-42.
[4.] Toroglu HT, Abdel-Dayem HM, Bonanno C. Gastric emptying patterns in Kaposi's sarcoma and gastroenteritis secondary to human immunodificiency virus infection. Clin Nucl Med 1994;19: 795-9.
[5.] Horowitz M, Fraser R. Disordered gastric motor function in diabetes mellitus. Diabetologia 1994;37:543-51.
[6.] Lartigue S, Biazis Y, Des Varannes B, Murat A, Pouliquen B, Galmiche JP. Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients. Dig Dis Sci 1994;39:109-15.
[7.] Ziegler D, Schadewaldt P, Pour Mirza A, Piolot R, Schommartz B, Reinhard M, et al. [[sup.13]C]Octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia 1996;39:823-30.
[8.] Fraser R, Horowitz M, Maddox A, Dent J. Dual effects of cisapride on gastric emptying and antropyloroduodenal motility. Am J Physiol 1993;264:G195-201.
[9.] Arienti V, Magri F, Boriani L, Maconi G, Bassein L, Baraldini M, et al. Effect of single dose of oral erythromycin on gastric and gallbladder emptying. Simultaneous assessment by ultrasound. Dig Dis Sci 1994;39:1309-12.
[10.] Uberschaer B, Ewe K, Alles U, Schmidtmann I. Effect of 4 X 250 mg erythromycin on human gastrointestinal transit. Z Gastroenterol 1995;33:340-4.
[11.] Cucchiara S, Raia V, Minella R, Frezza T, DeVizia B, DeRitis G. Ultrasound measurements of gastric emptying time in patients with cystic fibrosis and effect of ranitidine on delayed gastric emptying. J Pediatr 1996;128:485-8.
[12.] Tothil P, McLaughlin GP, Heading RC. Techniques and errors in scintigraphic measurement of gastric emptying. J Nucl Med 1978; 19:256-61.
[13.] Siegel JA, Urbain J-L, Adler LP, Charkes ND, Maurer AH, Krevsky B, et al. Biphasic nature of gastric emptying. Gut 1988;29:85-9.
[14.] Asada T, Murakami M, Sako Y, Fukushima Y, Yonekura Y, Konishi J, et al. Sulfamethizol capsule method. A new method for assessing gastric emptying of solids. Dig Dis Sci 1994;39:2056-61.
[15.] Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JMB, Zach D, et al. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989;ii:12-5.
[16.] Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993;104:1640-7.
[17.] Craig H. Isotope standards for carbon and oxygen and correction factors for mass spectrometric analysis of carbon dioxide. Geochim Cosmichim Acta 1957;12:133-49.
[18.] Cooper DE, Martinelli RU, Carlisle CB, Riris H, Bour DB, Menna RJ. Measurement of [sup.12]C[O.sub.2]:[sup.13]C[O.sub.2] ratios for medical diagnostics with 1.6 [micro]m distributed-feedback semiconductor diode lasers. Appl Optics 1993;32:6727:31.
[19.] Irving CS, Klein PD, Navratil P, Boutton W. Measurement of [sup.13]C[O.sub.2]/[sup.12]C[O.sub.2]-abundance by nondispersive infrared heterodyne ratiometry as an alternative to gas isotope ratio mass spectrometry. Anal Chem 1986;58:2172-8.
[20.] Milatz JMW, Kluyver JC, Hardebol J. Determination of isotope ratios, e.g. in tracer work, by an infrared absorption method J Chem Phys 1951;19:887-8.
[21.] Hirano S, Kanamatsu T, Takagi Y, Abei T. A simple infrared spectroscopic method for measurement of expired [sup.13]C[O.sub.2]. Anal Biochem 1979;96.64-9.
[22.] Braden B, Haisch M, Duan LP, Lembcke B, Caspary WF, Hering P. Clinically feasible stable isotope technique at a reasonable price: analysis of [sup.13]C[O.sub.2]/[sup.12]C[O.sub.2]-abundance in breath samples with a new isotope selective nondispersive infrared spectrometer. Z Gastroenterol 1994;32:675-8.
[23.] Koletzko S, Haisch M, Seeboth I, Braden B, Hengels K, Koletzko B, et al. Isotope-selective non-dispersive infrared spectrometry for detection of Helicobacter pylori infection with [sup.13]C-urea breath test. Lancet 1995;345:961-2.
[24.] Ohara H, Suzuki T, Nakagawa T, Yoneshima M, Yamamoto M, Tsujino D, et al. [sup.13]C-UTB using an infrared spectrometer for detection of Helicobacter pylori and for monitoring the effects of lansoprazole. J Clin Gastroenterol 1995;20(Suppl 2):S115-7.
[25.] Haisch M. Quantitative isotopenselektive Infrarotspektroskopie zur Bestimmung des Kohlenstoffisotopenverhaltnisses in der Atemluft [PhD Thesis]. Heinrich-Heine-Universitat, Dusseldorf, 1995.
[26.] Schoeller DA, Schneider JF, Solomons NW, Watkins J B, Klein PD. Clinical diagnosis with the stable isotope [sup.13]C in C[O.sub.2] breath tests: methodology and fundamental considerations. J Lab Clin Med 1977;90:412-21.
[27.] Shreeve WW, Cerasi E, Luft R. Metabolism of [[2.sup.-14] pyruvate in normal, acromegalic, and HGH treated human subjects. Acta Endocrinol 1970;65:155-69.
[28.] Haycock G, Schwartz G, Wisotsky D. Geometric method for measuring body surface area: a height-weight formula validated in infants, children and adults. J Pediatr 1978;93:62-6.
[29.] Maes BD, Ghoos YF, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, Vantrappen G. Combined carbon-13-glycine/carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids. J Nucl Med 1994;35:824-31.
PETER SCHADEWALDT, (1) * BERND SCHOMMARTZ, (2) GREGOR WIENRICH, (3) HERBERT BROSICKE; RALF PIOLOT, (1) and DAN ZIEGLER (1)
(1) Diabetes Forschungsinstitut, (2) Nuklearmedizinische Klinik, and (3) Kinderklinik, Heinrich-Heine-Universitit Dusseldorf, D-40225 Dusseldorf, Germany.
(4) Kinderklinik, Humbold-Universitat zu Berlin, D-13353 Berlin, Germany.
(5) Nonstandard abbreviations: IRMS, isotope ratio mass spectrometry; IRIS, isotope-selective nondispersive infrared spectrometry; and GEC, gastric emptying coefficient.
* Address correspondence to this author at: Diabetes Forschungsinstitut, Klinische Biochemie Auf'm Hennekamp 65, D-40225 Dusseldorf, Germany. Fax ++49-211-3382-603; e-mail email@example.com.
This work contains part of the Thesis of B.S.
Received July 1, 1996; revised September 23, 1996; accepted October 4, 1996.
Table 1. Reproducibility of [[sup.13]C]octanoic acid gastric-emptying breath test parameters. Parameters of reproducibility (linear regression analysis) Gastric emptying parameters Mean IRIS [t.sub.1/2, breath], min 100.7 [+ or -] 53.7 [t.sub.lag, breath], min 42.8 [+ or -] 32.6 GEC 2.90 [+ or -] 0.55 IRMS [t.sub.1/2, breath], min 79.0 [+ or -] 24.4 [t.sub.lag, breath], min 24.8 [+ or -] 16.1 GEC 3.33 [+ or -] 0.35 Parameters of reproducibility (linear regression analysis) Slope Intercept IRIS 0.997 [+ or -] 0.014 1.076 [+ or -] 1.572 1.045 [+ or -] 0.025 -0.798 [+ or -] 1.366 0.980 [+ or -] 0.021 0.049 [+ or -] 0.061 IRMS 1.006 [+ or -] 0.008 -0.065 [+ or -] 0.640 1.004 [+ or -] 0.004 -0.014 [+ or -] 0.116 0.998 [+ or -] 0.008 0.004 [+ or -] 0.026 Parameters of reproducibility (linear regression analysis) r [SD.sub.y-values] IRIS 0.9983 [+ or -] 3.240 0.9946 [+ or -] 3.640 0.9959 [+ or -] 0.050 IRMS 0.9995 [+ or -] 0.825 0.9999 [+ or -] 0.277 0.9995 [+ or -] 0.012 Data for gastric [t.sub.1-2, breath], [t.sub.lag, breath], and GEC were obtained by curve fitting by using nonlinear regression analysis as detailed in Subjects and Methods. Two analysis runs were performed on the samples from independent breath tests with 20 diabetic patients (10 male, 10 female; mean age 41.3 [+ or -] 16.6 years, weight 67.3 [+ or -] 10.8 kg, height 172 [+ or -] 10 cm) and 20 healthy volunteers (see methods section), respectively. Results from the first and second analysis were plotted on the x-and y-axes, respectively. Linear regression analysis (least-square method) was used for statistical evaluation. Data are presented as means [+ or -] SD (based on data from the first analysis run), when applicable. Table 2. Correlation of [[sup.13]C]octanoic acid gastric-emptying breath test parameters as computed on the basis of IRMS and IRIS [sup.13]C[O.sub.2] measurement. Mean Gastric emptying parameters IRMS IRIS [t.sub.1/2, breath], min 87.0 [+ or -] 38.7 90.4 [+ or -] 38.9 [t.sub.lag, breath], min 34.5 [+ or -] 27.3 34.4 [+ or -] 26.7 GEC 2.95 [+ or -] 0.50 2.85 [+ or -] 0.49 Correlation parameters (linear regression analysis) Gastric emptying parameters Slope Intercept [t.sub.1/2, breath], min 0.994 [+ or -] 0.021 4.061 [+ or -] 2.006 [t.sub.lag, breath], min 0.973 [+ or -] 0.016 0.960 [+ or -] 0.717 GEC 0.971 [+ or -] 0.025 -0.006 [+ or -] 0.073 Correlation parameters (linear regression analysis) Gastric emptying parameters r [s.sub.y|x] [t.sub.1/2, breath], min 0.987 66.271 [t.sub.lag, breath], min 0.992 63.432 GEC 0.982 60.093 Data for gastric [t.sub.1-2, breath], [t.sub.lag], breath, and GEC were obtained by curve fitting by using nonlinear regression analysis as detailed in Subjects and Methods. IRMS and IRIS measurements were performed on samples from 60 independent breath tests with diabetic patients and were plotted on the x-and y-axes, respectively (Fig. 2). Linear regression analysis (least-square method) was used for statistical evaluation. Data are presented as means [+ or -] SD, when applicable.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Automation and Analytical Techniques|
|Author:||Schadewaldt, Peter; Schommartz, Bernd; Wienrich, Gregor; Brosicke, Herbert; Piolot, Ralf; Ziegler, D|
|Date:||Mar 1, 1997|
|Previous Article:||Comparative evaluation of three assay systems for automated determination of hemoglobin [A.sub.1c].|
|Next Article:||Immunoassay of insulin-like growth factor binding protein-1.|